An Observational Study on Epithelioid Sarcoma

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorItalian Sarcoma Group

About this trial

Prospective Italian study aimed to provide a description of the population affected by Epithelioid Sarcoma (ES)

Eligibility criteria

Qualifiers

Histological diagnosis of epithelioid sarcoma according to 2014 World Health Organization (WHO) classification, performed on biopsy or surgical specimen

Signed informed consent

Adequate patient compliance to treatment or follow up

No age limit

Disqualifiers

Other malignancies within past 5 years, with exception of carcinoma in situ of the cervix and basocellular skin cancers treated with eradicating intent

Impossibility to ensure adequate compliance

Trial design

Treatments tested in this trial

  • Treatment for Epitheloid Sarcoma

Treatment groups

100 Participants
are divided into 1 treatment group

Locations

11
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST MeldolaFC, Italy
Istituto Europeo di Oncologia20141, MilanMI, Italy
Istituto Clinico Humanitas20089, RozzanoMI, Italy
Azienda Ospedaliera Universitaria Paolo Giaccone90127, PalermoPA, Italy

Sponsors and collaborators

Italian Sarcoma Group

Lead sponsor